Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study. Eur Urol 2026 Jul;90(1):85-87

Date

09/16/2025

Pubmed ID

40954009

DOI

10.1016/j.eururo.2025.09.003

Scopus ID

2-s2.0-105018024297 (requires institutional sign-in at Scopus site)   10 Citations

Author List

Jindal T, Jiang CY, Alhalabi O, Nguyen CB, Oh E, Tsung I, Bakaloudi DR, Talukder R, Davidsohn M, Freeman D, Epstein IY, Ding CC, Nizam A, Glover MJ, Khaki AR, Taylor AK, Lemke E, Jang A, Evans ST, Shin D, Pywell C, Basu A, Bilen MA, Zakharia Y, Barata P, Milowsky MI, Brown J, Kilari D, Emamekhoo H, Hoimes CJ, Shah S, Davis NB, Gupta S, Grivas P, Bellmunt J, Alva A, Campbell MT, Koshkin VS

Author

Deepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin